Company Filing History:
2 out of 16 
1 out of 832,843 Years Active: 2001-2007
Title: David Seymour Latchman: Innovator in Herpes Virus Research
Introduction
David Seymour Latchman is a notable inventor based in London, GB. He has made significant contributions to the field of virology, particularly in the study and manipulation of herpes viruses. With a total of three patents to his name, Latchman has focused on innovative methods for propagating mutant herpes viruses.
Latest Patents
Latchman's latest patents include a process for propagating a mutant herpes virus that has a mutation in its endogenous HSV VP16 gene. This process involves infecting a cell line with the mutant herpes virus and culturing the cell line, which contains a nucleic acid sequence that encodes a functional herpes simplex virus (HSV) VP16 polypeptide. The invention also provides cell lines that can be used for the growth of mutant herpes viruses with defects in certain immediate early genes. Another significant patent involves a herpes simplex virus strain that has a functional ICP27 gene while lacking at least a functional ICP4 gene and a functional ICP34.5 gene. This strain is proposed for use in treating disorders or injuries to the nervous system of mammals.
Career Highlights
Throughout his career, Latchman has worked with various companies, including Biovex Limited. His work has been instrumental in advancing the understanding of herpes viruses and their potential therapeutic applications.
Collaborations
Latchman has collaborated with notable individuals in his field, including Robert Stuart Coffin and Nicholas J Finnie. These collaborations have contributed to the development of his innovative research and patents.
Conclusion
David Seymour Latchman is a prominent figure in the field of herpes virus research, with a focus on innovative methods for virus propagation and treatment. His contributions continue to impact the scientific community and pave the way for future advancements in virology.